Newsletter Vol. 1, No. 2 References

ERECTILE DYSFUNCTION AND DEPRESSION:
IMPROVING QUALITY OF LIFE

Richard Sadovsky, MD

Bibliography

1. Sadovsky R. Integrating erectile dysfunction treatment into primary care practice. Am J Med. 2000;109(suppl 9A):22S-28S.

2. Sadovsky R, Mulhall JP. The potential value of erectile dysfunction inquiry and management. Int J Clin Pract. 2003;57:601-608.

3. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States. Prevalence and predictors. JAMA. 1999;281:537-544.

4. Hatzichristou D, Rosen RC, Broderick G, et al. Clinical evaluation and management strategy for sexual dysfunction in men and women. J Sex Med. 2004;1:49-57.

5. Perelman MA. Sex coaching for physicians: combination treatment for patient and partner. Int J Impot Res. 2003;15(suppl 5):S67-S74.

6. Seftel A, Sun P, Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus, and depression in men with erectile dysfunction. J Urol. 2004;171:2341-2345.

7. Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M. The multinational Men's Atittudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin. 2004;20:607-617.

8. Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. Am J Cardiol. 2000;86(suppl):41F-45F.

9. Seidman SN, Roose SP, Menza MA, Shabsigh R, Rosen RC. Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry. 2001;158:1623-1630.

10. Nurnberg HG, Hensley PL, Gelenberg AJ, Fava M, Laureillo J, Paine S. Treatment of antidepressant-associated sexual dysfunction with sildenafil. A randomized controlled trial. JAMA. 2003;289:56-64.

11. Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med. 1998;60:458-465.

12. Shabsigh R, Perelman MA, Laumann EO, Lockhart DC. Drivers and barriers to seeking treatment for erectile dysfunction: a comparison of six countries. BJU Int. 2004;94:1055-1065.

13. Shabsigh R, Klein LT, Seidman S, Kaplan Sa, Lehrhoff BJ, Ritter JS. Increased incidence of depressive symptoms in men with erectile dysfunction. Urology. 1998;52:848-852.

14. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual function in men older than 50 years of age: results from the Health Professionals Follow-up Study. Ann Intern Med. 2003;139:161-168.

15. Nurnberg HG, Seidman SN, Gelenberg AJ, Fava M, Rosen R, Shabsigh R. Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra^®) in treated and untreated patients with depression. Urology. 2002;60(suppl 2B):58-66.

16. Gelenberg AJ, Delgado P, Nurnberg HG. Sexual side effects of antidepressant drugs. Curr Psych Rep. 2000;2:223-227.

17. Nurnberg G, Segraves RT, Levine S, et al. Tadalafil is efficacious for the treatment of erectile dysfunction in a population of patients with comorbid clinical depression. Poster presented at: 7th Congress of the European Society for Sexual Medicine; December 5-8, 2004; London, England.

18. Hu L. Efficacy and safety of vardenafil in men with erectile dysfunction and depression. Zhonghua Nan Ke Xue. 2004;10:876-879.

19. Nurnberg HG, Gelenberg A, Hargreave T, Harrison WM, Siegel RL, Smith MD. Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Am J Psychiatry. 2001;158:1926-1928.